Abstract
ABSTRACT: In this case report, we used virtual reality (VR) to explore pain evoked by only the appearance of being touched (rather than actually being touched) in a person with complex regional pain syndrome type II. Furthermore, we explored the degree to which this visually evoked pain could be extinguished by applying exposure principles in VR. In stage 1, we identified 4 specific scenarios where pain was triggered by visually simulated touch (without physical stimulation) and used these scenarios to quantify baseline sensitivity to visuotactile stimulation. In stage 2, the patient undertook a 12-week virtual exposure program, and the visual triggers were reassessed 3 weeks after the commencement and immediately upon completion of the program. At baseline, severe pain and a profound cold sensation were immediately and consistently evoked in concert with visually simulated touch. At 12-week follow-up, only one of the initially provocative visual stimuli triggered pain and only after 60 seconds of repeated stimulation. Unfortunately, the transfer of desensitisation from VR to the real world was limited. This case report describes the phenomena of visually evoked pain. Moreover, it describes the near complete extinguishing of visually evoked pain through virtual graded exposure. How improvements gained in VR might be better transferred to real-word improvements merits further investigation.
Original language | English |
---|---|
Pages (from-to) | 1874-1878 |
Number of pages | 5 |
Journal | Pain |
Volume | 163 |
Issue number | 10 |
Early online date | 31 Jan 2022 |
DOIs | |
Publication status | Published - Oct 2022 |
Bibliographical note
Publisher Copyright:Copyright © 2022 International Association for the Study of Pain.
Funding
D.S.H. is supported by an Early Career Research Fellowship from the National Health and Medical Research Council of Australia (GNT1142929). TRS is supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia (GNT1141735). Deidentified data are available from the authors upon reasonable request by email. The study was not preregistered. All authors contributed meaningfully to the manuscript.
Funders | Funder number |
---|---|
National Health and Medical Research Council | GNT1141735, GNT1142929 |